Neue Suche | Kongressdetail
mail
Druckansicht
 
 

12th World Clinical Biomarkers and CDx Summit

Evvnt Promotion / evvnt
-
28.09.2022 - 29.09.2022  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, USA
Time: 6:50 am to 4:35 pm
 
Kongressthemen
The 12th World Clinical Biomarkers and CDx Summit returns at a crucial time for the entire precision and targeted drug development industry. Spurred on by a number of recent exciting biomarker-driven therapy and CDx approvals by the FDA, including Eli Lilly's Verzenio, J&J's Amivantamab and Takeda's Mobocertinib, the race to market is becoming ever fiercer to deliver the next-generation of safer and more effective therapies for defined patient populations.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Anmerkungen
Speakers: Aaron Schetter, Senior Director, Regulatory Affairs, Companion Diagnostics, Daiichi Sankyo, Inc., Amy Gorman, Director, Global Commercial Strategy, Precision Medicine, Janssen, Antonio Chambers, Associate Director, Technical Diagnostic Test
 

Anfragen und Anmeldung:

https://go.evvnt.com/1145208-2?pid=4832
Frau Anita Kelemen
 
Kategorien
Allgemeinmedizin, Medizinische und chemische Labordiagnostik
Sprache
Englisch
Kongressgebühr
Free: USD 0.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Österreichisches Rotes KreuzCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioCharité International AcademyHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public HealthSwiss Tropical and Public Health InstituteEuropean Health Forum GasteinAGEM - Arbeitsgemeinschaft Ethnologie und Medizin